News by subject: Conference

Kite, a Gilead Company , today announced the results of four new analyses supporting the use of Tecartus® (brexucabtagene autoleucel) in relapsed/refractory mantle cell lymphoma (R/R MCL) and relapsed/refractory adult B-cell precursor acute...

Kite, a Gilead Company , today announced results from a three-year follow-up analysis of ZUMA-12, a Phase 2 study of Yescarta® (axicabtagene ciloleucel) as first-line treatment after two cycles of chemoimmunotherapy in patients with high-risk, large...

Novanta Inc. (the "Company"), a trusted technology partner to medical and advanced technology equipment manufacturers, announced today that Matthijs Glastra, Chair & Chief Executive Officer, and Robert Buckley, Chief Financial Officer, are scheduled...

McGrath RentCorp ("McGrath" or the "Company") , a leading business-to-business rental company in North America, today announced that Joe Hanna, Chief Executive Officer, and Keith Pratt, EVP, and Chief Financial Officer, will participate in investor...

Demonstrating a remarkable ongoing commitment to excellence, Gables Residential was recognized with two Multifamily Leadership Awards. Gables ranked #2 in the Best Places to Work Multifamily® rankings by Multifamily Leadership and recognized with the...

Royal Gold, Inc. (together with its subsidiaries, "Royal Gold" or the "Company," "we" or "our") announced today that management will present in the live Virtual Non-Deal Roadshow Series hosted by Renmark Financial Communications Inc. Alistair Baker,...

Physicians and scientists with City of Hope, one of the largest cancer research and treatment organizations in the United States, presented data on potential new treatment options for blood cancers at this year's American Society of Hematology (ASH)...

Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, today announced preclinical...

MEI Pharma, Inc. , a clinical-stage pharmaceutical company evaluating novel drug candidates to address known resistance mechanisms to standard-of-care cancer therapies, today announced clinical data from the monotherapy dose escalation stage of the...

PGT Innovations, Inc. , a national brand and innovation leader in the fenestration and garage door industries, is pleased to announce that products from its WINDOOR and PGT Custom Windows and Doors brands were used in every home featured on season...

Operation HOPE, Inc.: WHAT: Operation HOPE is pleased to announce that artificial intelligence pioneer Sam Altman will be making his first public appearance since rejoining Open AI as CEO on stage at the 2023 Annual Meeting of the Hope Global...

The rapid onset of artificial intelligence enables new possibilities for innovation and collaboration ? whether at work or at play. It is driving a fundamental shift in computing that promotes interconnectivity between technology and humanity. From...

The Menarini Group ("Menarini"), a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc. ("Stemline"), a wholly-owned subsidiary of the Menarini Group, focused on bringing transformational oncology treatments...

Intel Labs is showcasing some of its most significant and industry-first AI innovations at NeurIPS 2023 ? the leading global event for developers, researchers, and academic professionals focused on AI and computer-vision technologies. The event takes...

Butterfly Network, Inc. ("Butterfly") a digital health company transforming care with handheld, whole-body ultrasound and intuitive software, today announced that it will participate at the 42nd Annual J.P. Morgan Healthcare Conference taking place...

Reimagine Care, the nation's leading provider of virtual and in-home cancer care, along with CU Innovations at the University of Colorado Anschutz Medical Campus (CU), a leading research institution committed to fostering innovation and excellence in...

Wharton Research Data Services (WRDS) and SSRN are pleased to announce The Chinese University of Hong Kong, Shenzhen as winner of the 2023 WRDS-SSRN Innovation Award. Annual awards are presented to rising business schools in the North America, EMEA,...

2seventy bio, Inc. , a leading immuno-oncology cell therapy company, announced today that the Company will host a conference call on Tuesday, December 12, 2023, at 8:00am ET. The event will highlight data presented at the 65th American Society of...

Seneca Therapeutics, Inc. (STI), announced today that Dr. Paul Hallenbeck will present a talk at the 8th Oncolytic Virotherapy Summit 2023 entitled "Assessing the Benefits and Challenges of Intravenous Delivery of Oncolytic Viruses". In his talk, Dr....

Regulatory News: MaaT Pharma (EURONEXT: MAAT ? the "Company"), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to enhancing survival of patients with cancer, presented...

On December 7, 2023, the opening ceremony of the first Child-Friendly Expo (hereinafter referred to as "CFE") was held at Hall 2 of the Shenzhen Convention & Exhibition Center (Futian). Initiated by the Shenzhen Women's Federation, the CFE is the...

Bristol Myers Squibb announced the first disclosure of primary analysis results from the high-risk, second-line cohort of TRANSCEND FL, an open-label, global, multicenter, Phase 2, single-arm study evaluating Breyanzi® (lisocabtagene maraleucel,...

Positive results from the 24-week and long-term extension (LTE) period of the pivotal ALPHA Phase III trial showed danicopan as add-on to standard of care C5 inhibitor therapy ULTOMIRIS® (ravulizumab-cwvz) or SOLIRIS® (eculizumab) continued to...

Seagen Inc. today announced that clinically meaningful progression-free survival (PFS), a secondary endpoint, was observed in a Phase 2 study evaluating the antibody-drug conjugate (ADC) ADCETRIS® (brentuximab vedotin) in combination with the PD-1...

MorphoSys AG today announced comprehensive results from the Phase 3 MANIFEST-2 study investigating pelabresib, an investigational BET inhibitor, in combination with the JAK inhibitor ruxolitinib in JAK inhibitor-naïve patients with myelofibrosis....

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that new data from its CD20xCD3 T-cell engaging bispecific antibody program, including eight oral presentations, were presented at the 65th American Society of...

InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the latest data from InnoCare's oncology studies were presented at the 65th American...

Incyte and Syndax Pharmaceuticals today announced the full results from the pivotal Phase 2 AGAVE-201 trial of axatilimab, an anti-CSF-1R antibody, in adult and pediatric patients with refractory chronic graft-versus-host disease (GVHD) who had...

Be Biopharma, Inc. ("Be Bio"), a company pioneering the discovery and development of Engineered B Cell Medicines (BCMs), today announced results from a new preclinical study demonstrating that the company's novel engineered BCM, BE-101, produces...

Adicet Bio, Inc. , a clinical stage biotechnology company discovering and developing allogeneic gamma delta T cell therapies for cancer, today announced that an abstract outlining PK and PD profiling data from the Company's ongoing Phase 1 study of...

GlycoMimetics, Inc. , a late clinical-stage biotechnology company discovering and developing glycobiology-based therapies for cancers and inflammatory diseases, today announced the 65th American Society of Hematology (ASH) Annual Meeting will feature...

Updated data from bluebird bio inc.'s gene therapy program in transfusion-dependent (TDT) beta-thalassemia were presented today at the 65th American Society of Hematology (ASH) Annual Meeting & Exposition. Updated follow-up data showed sustained...

ImmunoGen Inc. , a leader in the expanding field of antibody-drug conjugates (ADCs) for the treatment of cancer, today announced new safety and efficacy findings from the newly diagnosed (ND) cohorts of the Phase 1b/2 study of pivekimab sunirine...

Schrödinger , whose physics-based computational platform is transforming the way therapeutics and materials are discovered, today announced new preclinical data on SGR-1505, its investigational MALT1 inhibitor, and SGR-2921, its investigational CDC7...

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today announced positive final results from the Phase 2 TELLOMAK study in Sézary Syndrome (SS). The results were presented at the ASH 2023 Annual Meeting, in San Diego,...

Pfizer Inc. today presented results from the pivotal Phase 3 BASIS clinical trial (NCT03938792) evaluating marstacimab for the treatment of people with severe hemophilia A and moderately severe to severe hemophilia B without inhibitors to Factor...

Orca Bio, a late-stage biotechnology company developing high-precision cell therapies for the treatment of cancer, autoimmune diseases and genetic blood disorders, today announced positive new data that suggest its investigational high-precision cell...

Bristol Myers Squibb announced updated results from the primary analysis of the Phase 3 COMMANDS trial, comparing Reblozyl® (luspatercept-aamt) versus epoetin alfa for the treatment of anemia in erythropoiesis stimulating agent (ESA)-naïve patients...

Rallybio Corporation , a clinical-stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare diseases, today presented details from the Rallybio Fetal and...

bluebird bio, Inc. ("bluebird bio" or "bluebird") today announced new and updated efficacy, safety and health-related quality of life (HRQoL) data from the Phase 1/2 HGB-206 Group C and Phase 3 HGB-210 studies of lovotibeglogene autotemcel...

Today, at COP28 in the UAE, the city of Dire Dawa (Ethiopia) Water Supply and Sewerage Authority (DDWSSA) and Nedamco Africa together with its partners Microsoft, Deltares, Hulo.ai and Isle Utilities announced the launch of the "Nedamco...

Bob's Discount Furniture, one of the fastest growing omnichannel furniture retailers in the country, recently received Furniture Today's prestigious "Furniture Industry Leadership" award for the company's value proposition, performance, and...

City of Hope, one of the largest cancer research and treatment organizations in the United States, will present innovative research at this year's San Antonio Breast Cancer Symposium (SABCS), taking place Dec. 5 to 9 in San Antonio, Texas. Each...

Ribometrix, a biotechnology company developing small molecule therapeutics that modulate RNA biology, today presented preclinical data supporting the potential of its eIF4E inhibitors in Estrogen Receptor-positive (ER+) breast cancer at the annual...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), presented today positive results from the Phase III INAVO120 study evaluating inavolisib in combination with palbociclib (Ibrance®) and fulvestrant as a first-line treatment for...

San Diego Angel Conference at the University of San Diego (SDAC) activates angel investors and connects them with early-stage companies seeking seed funding. By providing a low initial investment and robust deal flow, SDAC enables accredited...

Marchex , the award-winning AI-powered conversation intelligence company that helps businesses turn strategic insights into the actions that drive their most valued sales outcomes, today announced that CEO Edwin Miller will participate in a fireside...

ReNew Energy Global Plc ("ReNew") , India's leading renewable energy company, has been named a Clean Energy Transition Changemaker by the COP28 Presidency for its work on the Round-the-Clock Power Project. Energy Transition Changemakers is a new...

Thousands of ambulatory healthcare professionals from across the US traveled to Orlando last week to gather insights on navigating the ever-changing healthcare landscape, including how to leverage artificial intelligence (AI) to reduce provider...

Expro Group Holdings N.V. today announced that Michael Jardon, Chief Executive Officer, will participate in a panel discussion at the Goldman Sachs Energy, CleanTech and Utilities Conference at 1:40 p.m. ET on Thursday, January 4, 2024. Mr. Jardon...